Moreover, these findings indicate an outstanding role for CD83 as a potent immune modulating molecule in EAE and multiple sclerosis as well as a potential candidate for Treg-targeted immunotherapy in autoimmune diseases. Here, CD83 is linked to multiple sclerosis.